Recent Company News

• 04:18 PM ET Oct 06, 2026
  

  FDA notes increased reports of allergic/hypersensitivity with one lot of Yimmugo (€9.88, 0.00)

• 06:48 AM ET Oct 06, 2026
  

  StreetAccount Summary - European unusual volume traders

• 07:06 AM ET Aug 10, 2026
  

  Grifols announces the completion of the clinical portion of SPARTA study; Top line results expected by the end of 2026 (€10.04, -0.14)

• 02:23 PM ET Jul 28, 2026
  

  Transcript Intelligence: Grifols Q2 Earnings Guidance

• 02:23 PM ET Jul 28, 2026
  

  Transcript Intelligence: Grifols Q2 Earnings Themes

• 02:23 PM ET Jul 28, 2026
  

  Transcript Intelligence: Grifols Q2 Earnings Q&A

• 11:54 AM ET Jul 28, 2026
  

  StreetAccount Metrics Recap - Grifols Q2 Earnings (€9.99, 0.00)

• 11:54 AM ET Jul 28, 2026
  

  Grifols reports Q2 net income €155M vs consensus €120.2M; on track to deliver its 2026 guidance (€9.99, 0.00)

• 06:22 AM ET Jul 27, 2026
  

  StreetAccount Consensus Metrics Preview - Grifols Q2 Earnings (€9.78, +0.13)

• 07:08 PM ET Jul 21, 2026
  

  President Trump states tariff on generic drugs will stay at 0% for 2 years then rise to 100% - Truth Social